Benoit Arsenault | Laval University | Canada | [Session 6] Hypertriglyceridemic Waist: A simple Tool |
Philip Barter | University of New South Wales | Australia | [Session 1] [Session 4] HDL as a Therapeutic Target: A Critical Appraisal |
André Carpentier | Sherbrooke University | Canada | [Session 2] Partition of Dietary Fatty Acid Metabolism in Type 2 Diabetes |
Juliana Chan | Chinese University of Hong Kong | China (HK) | [Session 1] Type 2 Diabetes and Cardiometabolic Risk in Asia |
Peter Clifton | University of South Australia | Australia | [Session 8] Nutrition and CVD Prevention: What Should We Aim For? |
Jean-Pierre Després | Laval University | Canada | [Session 7] Targeting Cardiometabolic Risk in Clinical Practice: Is Weight Loss the Right Target? |
Amalia Gastaldelli | Institute of Clinical Physiology of CNR of Pisa | Italy | [Session 4] Ectopic Fat: The True Culprit Linking Obesity and Cardiovascular Disease? |
Frank Hu | Harvard Medical School | USA | [Session 9] Healthy Drinking: An Important Component of a Healthy Lifestyle |
Michael Jensen | Mayo Clinic | USA | [Session 1] Jean Vague & Per Björntorp Award |
Fredrik Karpe | University of Oxford | UK | [Session 3] Molecular Aspects of Insulin Resistance in Abdominal Obesity |
Hyo-Soo Kim | Seoul National University Hospital | Korea | [Session 4] Cloning of New Receptor for Resistin: Mechanism of Inflammation at Adipose Tissue and Atherosclerosis |
Jae Bum Kim | Seoul National University | Korea | [Session 5] Lipid Dysregulation and Metabolic Complications |
Yangha Kim | Ewha Womans University | Korea | [Session 5] Thermogenic Agent in the Management of Cardiometabolic Risk |
Kwang Kon Koh | Gachon University Gil Hospital | Korea | [Session 6] To Target or not To Target LDL-Cholesterol? That is the Question |
Benoît Lamarche | Laval University | Canada | [Session 8] Reshaping Nutritional Habits in Clinical Practice |
In Kyu Lee | Kyungpook National University | Korea | [Session 5] Regulation of PDH (Pyruvate Dehydrogenase) Flux and Insulin Resistance in Vascular Calcification |
Peter Libby | Brigham and Women's Hospital | USA | [Session 4] Abdominal Obesity, Type 2 Diabetes and Cardiovascular Disease: Is Inflammation the Missing Link? |
Soo Lim | Seoul National University Bundang Hospital | Korea | [Session 1] Abdominal Obesity in Korea |
André Marette | Laval University | Canada | [Session 3] Inflammation, Adipose Tissue and Cardiometabolic Risk |
Yuji Matsuzawa | Osaka University | Japan | [Session 1] Abdominal Obesity: State of the Art |
Kyong Soo Park | Seoul National University Hospital | Korea | [Session 5] Nuclear Receptors and Fatty Acid Metabolism in Skeletal Muscle |
Denis Richard | Laval University | Canada | [Session 6] Global Cardiometabolic Approach Organization as a Model (CMDO) |
Robert Ross | Queen's University | Canada | [Session 7] Physical Activity/Exercise in the Management of Abdominal Obesity |
Ulf Smith | University of Gothenburg | Sweden | [Session 3] Abdominal Obesity, Adipocytes and Inflammation |
Mitsuyoshi Takahara | Osaka University Graduate School of Medicine | Japan | [Session 3] Obesity, Adiponectin and Cardiometabolic Risk: An Update |
Marja-Riitta Taskinen | Helsinki University | Finland | [Session 2] Ectopic Fat: An Important Feature of Visceral Obesity and Type 2 Diabetes |
André Tchernof | Laval University | Cananda | [Session 2] Visceral Adipose Tissue Metabolism in Human |
Luc Van Gaal | Antwerp Univeristy Hospital | Belgium | [Session 6] Targeting Abdominal Obesity in Diabetology: What Can We Do? |
Samuel Virtue
| University of Cambridge | UK | [Session 3] Adipose Tissue and Cardiometabolic Risk: Mechanistic Insights |